---
$id: https://graph.org.ai/products/commodity/51313117
$type: Product
source: UNSPSC
code: "51313117"
title: "Clocinizine hydrochloride"
class: "51313100"
classTitle: "Antihistamine or H1 blocker piperazines"
family: "51310000"
familyTitle: "Antihistamines or H1 blockers"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Clocinizine hydrochloride

**UNSPSC Code**: 51313117
**Class**: [Antihistamine or H1 blocker piperazines](Antihistamine or H1 blocker piperazines.mdx)
**Family**: [Antihistamines or H1 blockers](../Antihistamines or H1 blockers.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a histamine-1 receptor antagonist with the molecular formula C26H27CLN2.2CLH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier AE8KM1QU3Q. European Medicines Agency schedules clocinizine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01350MIG. The term clocinizine hydrochloride is a U.S. FDA designation. Most nations, for tariff and trade purposes, schedule clocinizine hydrochloride under HS 29335995 and SITC 51576. As of Q4 2014, CLOCINIZINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Clocinizine hydrochloride bears US NLM identifiers UMLS ID C3273574 and NCI Concept Code C97696. SMILES: C1CCC(CC1)/C=C/CN2CCN(CC2)C(C3CCCCC3)C4CCC(CC4)CL.CL.CL.

